HOME >> BIOLOGY >> NEWS
Springer editor and author Koki Horikoshi to receive 2006 Japan Academy Prize

Koki Horikoshi (73), professor emeritus at the Tokyo Institute of Technology and Director General of Extremobiosphere Research Center JAMSTEC, has been honored with this year's Japan Academy Prize. The award ceremony was held on July 3, 2006, in the presence of Their Majesties the Emperor and Empress of Japan.

Prof. Horikoshi received the award for his studies on the diversity, physiology, and application of alkaliphilic microorganisms. He was the first person in the world to isolate alkaliphiles (alkaline-loving microorganisms) and opened up a new vista of the microbial world. His creative studies have influenced microbiology throughout the world and established the foundations of a new field of biological research into extremophiles, i.e. microorganisms that prefer extreme conditions. He has also conducted extensive screening for the enzymes produced by alkaliphiles, and made a great impact on industrial applications.

Koki Horikoshi was born in Saitama (Japan) in 1932. He obtained a B.A. and a Ph.D. from the University of Tokyo. He is the author of Alkaliphiles: Genetic Properties and Applications of Enzymes (2006), published by Springer. He founded Springer's international journal Extremophiles and has helped develop the journal as Editor-in-Chief since 1997. He also set up the International Society for Extremophiles in 2002 as founding president and is a lifetime honorary president of the society. He has received many awards for his scientific work, including the Purple Medal (1987), the Gold Medal from the UK's International Biotechnology Society (1991) and the Honda Prize (1992).


'"/>

Contact: Joan Robinson
joan.robinson@springer.com
496-221-487-8130
Springer
20-Jul-2006


Page: 1

Related biology news :

1. Springer launches Theoretical Ecology
2. Springer ecology book wins award for excellence
3. Springer author receives prestigious award in Beijing
4. Springer adds Genomic Medicine to biomedical publishing portfolio
5. Springer launches new journal, Cognitive Neurodynamics
6. Springer to publish new journal Systems and Synthetic Biology
7. Springer expands life science program with In Vitro journals
8. Springer author Alan Hastings wins Robert H. MacArthur Award
9. Springer acquires BioTribune Magazine and Biotribune.com
10. Springer joins Katrina relief effort with eBooks donation worth more than $1 million
11. Press Week for science writers, reporters and editors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
(Date:2/16/2017)... , ... February 16, 2017 , ... ... case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on ... performed on a 55-year-old practicing female physician suffering from degenerative disc disease with ...
Breaking Biology Technology:
Cached News: